rs41305223
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001034853.2(RPGR):c.1033A>G(p.Asn345Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,203,141 control chromosomes in the GnomAD database, including 51 homozygotes. There are 3,751 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).
Frequency
Consequence
NM_001034853.2 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 3Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- RPGR-related retinopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- primary ciliary dyskinesia-retinitis pigmentosa syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- macular degeneration, X-linked atrophicInheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RPGR | ENST00000645032.1 | c.1033A>G | p.Asn345Asp | missense_variant | Exon 9 of 15 | NM_001034853.2 | ENSP00000495537.1 | |||
| ENSG00000250349 | ENST00000465127.1 | c.172-364848T>C | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes AF: 0.00710 AC: 791AN: 111428Hom.: 2 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.00706 AC: 1268AN: 179715 AF XY: 0.00660 show subpopulations
GnomAD4 exome AF: 0.0104 AC: 11320AN: 1091663Hom.: 49 Cov.: 27 AF XY: 0.00992 AC XY: 3547AN XY: 357487 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00709 AC: 790AN: 111478Hom.: 2 Cov.: 22 AF XY: 0.00605 AC XY: 204AN XY: 33718 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2Other:1
This variant is associated with the following publications: (PMID: 10937588, 11857109) -
- -
- -
Primary ciliary dyskinesia Benign:2
- -
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not specified Benign:1
- -
RPGR-related retinopathy Benign:1
NM_001034853.2(RPGR):c.1033A>G (p.Asn345Asp) is a missense variant predicted to cause substitution of asparagine by aspartic acid at amino acid 345. This variant is present in gnomAD v4.1.0 at a frequency of 0.009588 among hemizygous individuals, with 3,751 variant alleles / 391,205 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). The computational predictor REVEL gives a score of 0.241, which is below the ClinGen X-linked IRD VCEP threshold of <0.290 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.01, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1 and BP4. (date of approval 05/16/2025). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at